12-Aug-2009 - Labcyte Inc.

Labcyte Expands Presence in Chinese Market

Labcyte announced the selection of Tekon Biotech as its exclusive distributor in China, including Hong Kong and Taiwan.

“Tekon, one of the leading distributors in China, will be a great partner for us,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Service of Labcyte Inc. “As we expand in Asia, Tekon will help us broaden our existing user base in the pharmaceutical industry and the contract research organizations (CROs) that service them. Tekon will provide them with technology from Labcyte for industry-leading compound management, high-throughput and secondary screening. Our established customers in China will find that Tekon will give them an opportunity for more immediate support and interaction. Tekon will also introduce us to new users in the growing genomics market. We feel that with the Labcyte platforms, Tekon can meet the genomics customers’ needs for miniaturization, precision and accuracy while remaining contamination-free.”

Facts, background information, dossiers
  • Labcyte
  • genomics
  • Tekon Biotech
  • Taiwan
  • contract research
  • bases
More about Labcyte
  • News

    Beckman Coulter strenghtens laboratory automation business

    Beckman Coulter Life Sciences announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California. Labcyte is best known for its Echo® acoustic droplet ejection technology, which uses sound waves to transfer tiny amounts of liquid with une ... more

    Labcyte Awarded 1st Patent in China

    Labcyte announced the grant of its first patent in China. Patent CN 101035681B describes how acoustic energy is used to assess the characteristics of any fluid in real time to optimize its transfer. The Labcyte acoustic droplet ejection technology offers touchless transfer of a wide variety ... more

    Labcyte Awarded US Patent for Real-Time Power Optimization

    Labcyte announced the grant of its 40th US patent. Patent number 7,717,544 describes how in real time acoustic energy is optimized to transfer a droplet of any fluid, even those that are unknown. Labcyte’s acoustic droplet ejection technology offers touchless transfer of a wide variety of f ... more

More about Tekon Biotech
  • News

    Labcyte Awarded 1st Patent in China

    Labcyte announced the grant of its first patent in China. Patent CN 101035681B describes how acoustic energy is used to assess the characteristics of any fluid in real time to optimize its transfer. The Labcyte acoustic droplet ejection technology offers touchless transfer of a wide variety ... more